Abstract | PURPOSE: EXPERIMENTAL DESIGN: RESULTS: In this model, microcomputed tomography imaging showed that apomab, chemotherapy, or combination treatment significantly inhibited tumor growth compared with vehicle, whereas the combination caused greater inhibition in tumor growth relative to chemotherapy or apomab. Similarly, histologic analysis revealed that apomab, chemotherapy, or the combination significantly reduced tumor size compared with vehicle, whereas the combination induced significantly greater reduction in tumor size than did chemotherapy or apomab. Furthermore, combined treatment improved 105-day survival relative to vehicle (P = 0.0023) as well as to apomab (P = 0.0445) or chemotherapy (P = 0.0415). CONCLUSION: These results show a positive interaction of apomab with chemotherapy, evidenced by significant inhibition of tumor growth as well as improved survival, thus supporting further investigation of this therapeutic approach in lung cancer patients.
|
Authors | Hongkui Jin, Renhui Yang, Jed Ross, Sharon Fong, Richard Carano, Klara Totpal, David Lawrence, Zhong Zheng, Hartmut Koeppen, Howard Stern, Ralph Schwall, Avi Ashkenazi |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 14
Issue 23
Pg. 7733-40
(Dec 01 2008)
ISSN: 1078-0432 [Print] United States |
PMID | 19047100
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Receptors, TNF-Related Apoptosis-Inducing Ligand
- apomab
- Carboplatin
- Paclitaxel
|
Topics |
- Animals
- Antibodies, Monoclonal
(administration & dosage)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Apoptosis
(drug effects)
- Carboplatin
(administration & dosage)
- Carcinoma, Non-Small-Cell Lung
(drug therapy)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Female
- Humans
- Immunoblotting
- In Situ Nick-End Labeling
- Lung Neoplasms
(drug therapy)
- Mice
- Mice, Nude
- Paclitaxel
(administration & dosage)
- Receptors, TNF-Related Apoptosis-Inducing Ligand
(agonists, drug effects)
- Xenograft Model Antitumor Assays
|